These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 21839245

  • 21. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 22. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation.
    Jacques F, Carrier M, Pelletier GB, Racine N, White M, Perrault LP, Pellerin M.
    Transplant Proc; 2009 Oct; 41(8):3337-41. PubMed ID: 19857745
    [Abstract] [Full Text] [Related]

  • 23. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct; 36(8):2384-5. PubMed ID: 15561256
    [Abstract] [Full Text] [Related]

  • 25. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 26. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W, Sherrill B, Brennan DC, Lowell J, Schnitzler M.
    Transplantation; 2003 Dec 27; 76(12):1686-90. PubMed ID: 14688516
    [Abstract] [Full Text] [Related]

  • 27. Clinical experience of tacrolimus with everolimus in heart transplantation.
    Wang SS, Chou NK, Chi NH, Huang SC, Wu IH, Wang CH, Yu HY, Chen YS, Tsao CI, Ko WJ, Shun CT.
    Transplant Proc; 2012 May 27; 44(4):907-9. PubMed ID: 22564581
    [Abstract] [Full Text] [Related]

  • 28. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 29. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
    Fuchs U, Klein S, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Ann Transplant; 2014 Jun 23; 19():300-4. PubMed ID: 24953848
    [Abstract] [Full Text] [Related]

  • 30. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec 23; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 31. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 23; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 32. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H, European and Australian Investigators in Lung Transplantation.
    J Heart Lung Transplant; 2012 Aug 23; 31(8):797-804. PubMed ID: 22554673
    [Abstract] [Full Text] [Related]

  • 33. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E, Harber M, Bhagani S, Levy J, Jones R, Hilton R, Davies G, Post FA, UK HIV Kidney Transplantation Study Group.
    Transplantation; 2016 Apr 23; 100(4):871-8. PubMed ID: 26413990
    [Abstract] [Full Text] [Related]

  • 34. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B.
    Transplantation; 2008 Oct 15; 86(7):953-60. PubMed ID: 18852662
    [Abstract] [Full Text] [Related]

  • 35. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
    Fan Y, Xiao YB, Weng YG.
    Transplant Proc; 2009 Jun 15; 41(5):1821-4. PubMed ID: 19545736
    [Abstract] [Full Text] [Related]

  • 36. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y, Ersoy A, Ocakoglu G, Yildiz A, Oruc A, Soyak H, Calapkulu M, Sahin AB, Topal NB, Okeer E, Coskun B, Kaygisiz O, Kordan Y, Vuruskan H.
    Transplant Proc; 2017 Mar 15; 49(2):270-277. PubMed ID: 28219583
    [Abstract] [Full Text] [Related]

  • 37. Evolution of rejection rates and kidney graft survival: a historical analysis.
    Marcén R, Fernández-Rodriguez A, Rodríguez-Mendiola N, Ponte B, Galeano C, Villafruela JJ, Teruel JL, Burgos FJ, Ortuño J.
    Transplant Proc; 2009 Mar 15; 41(6):2357-9. PubMed ID: 19715918
    [Abstract] [Full Text] [Related]

  • 38. A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation.
    Sánchez-Lázaro IJ, Almenar L, Martínez-Dolz L, Buendía-Fuentes F, Agüero J, Navarro-Manchón J, Vicente JL, Salvador A.
    Clin Transplant; 2011 Mar 15; 25(4):606-13. PubMed ID: 20682020
    [Abstract] [Full Text] [Related]

  • 39. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D, Keitel E, Heineck I, Cardoso BD, Rodrigues AP, Michel K, Garcia VD.
    Transplant Proc; 2010 Mar 15; 42(2):475-8. PubMed ID: 20304169
    [Abstract] [Full Text] [Related]

  • 40. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
    Pollock-Barziv SM, Dipchand AI, McCrindle BW, Nalli N, West LJ.
    J Heart Lung Transplant; 2005 Feb 15; 24(2):190-4. PubMed ID: 15701436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.